Peter H. Wiernik
Continuum Cancer Centers of New York
St. Lukes-Roosevelt and Beth Israel Medical Center
Leukemia Program
1000 10th Ave
USA
Name/email consistency: high
- Lenalidomide in lymphomas and chronic lymphocytic leukemia. Wiernik, P.H. Expert. Opin. Pharmacother (2013)
- FLT3 inhibitors for the treatment of acute myeloid leukemia. Wiernik, P.H. Clin. Adv. Hematol. Oncol (2010)
- Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up. Wiernik, P.H., Hong, F., Glick, J.H., Bennett, J.M. Leuk. Lymphoma (2009)
- Plasma cell dyscrasias and leukemias. Wiernik, P.H. Cancer. Chemother. Biol. Response. Modif (2005)
- Second neoplasms in patients with chronic lymphocytic leukemia. Wiernik, P.H. Curr. Treat. Options. Oncol (2004)
- Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998). Wiernik, P.H., Paietta, E., Goloubeva, O., Lee, S.J., Makower, D., Bennett, J.M., Wade, J.L., Ghosh, C., Kaminer, L.S., Pizzolo, J., Tallman, M.S. Leukemia (2004)
- A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486). Wiernik, P.H., Cassileth, P.A., Leong, T., Hoagland, H.C., Bennett, J.M., Paietta, E., Oken, M.M. Leuk. Lymphoma (2003)
- Plasma cell myeloma and leukemia. Wiernik, P.H. Cancer. Chemother. Biol. Response. Modif (2003)